Home
Clinical Resources Search
PQI: Social Determinants of Health in Cancer

Social Determinants of Health in Cancer

Download PQI pdf 0.19MB

Last Updated: December 19, 2023

By: Tahsin Iman, PharmD | Elizabeth Heard, PharmD

About this PQI

This PQI identifies social determinants of health (SDOH) as they relate to cancer patients and incorporates strategies to address patients’ social needs.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Cancer Supportive Care

PQI

Frequently Searched

Supported by

Social Determinants of Health in Cancer

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Encorafenib (Braftovi®) + Cetuximab (Erbitux®) + mFOLFOX6 for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI: Zolbetuximab (Vyloy®) for Gastroesophageal Cancers

PQI: Advances in MRD Monitoring for Diffuse Large B-Cell Lymphoma (DLBCL)

PQI: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI in Action: Larotrectinib (Vitrakvi®) Overview

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease

S8 Bonus Eps 2: Inside ASCO 2025

S8 E15: Supporting Survivors at Work

S8 E14: Advancing Geriatric Oncology

S8 Ep 13: Supporting Patients Through Financial Assistance

Readiness Tracker

Treatment Support Kit: Mirdamentinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

S8 Ep 10: Operationalizing Bispecifics in the Community Setting

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings

The PQI Podcast S3 Ep 13: The Importance of the Multidisciplinary Team

The PQI Podcast S4 Ep 5: Role of Oncology Social Worker

The PQI Podcast S4 Ep 6 : Community Pharmacy and Ohio Board of Pharmacy

The PQI Podcast S4 Ep 9: Mental Illness and Burnout

The PQI Podcast S4 Ep 10: Oncology Wellness & Exercise

Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings

Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure

Example SOPs and Documents: Bispecific T-Cell Engager Ordering and REMS Compliance

Example SOPs and Documents: On-Call Responsibilities for Nurses Managing Bispecific T-Cell Engagers